Cesarean Section Scar Evaluation by Saline Contrast Sonohysterography During Hysteroscopy
1 other identifier
observational
60
1 country
1
Brief Summary
To apply an existing diagnostic imaging test (saline infusion sonohysterography by Hysteroscopic) to characterize the "filling defect" of a previous cervical cesarean delivery scar in the nonpregnant uterus
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2016
CompletedFirst Submitted
Initial submission to the registry
August 10, 2016
CompletedFirst Posted
Study publicly available on registry
August 12, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2018
CompletedAugust 12, 2016
August 1, 2016
2 years
August 10, 2016
August 10, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Cesarean Section Scar Evaluation by TVU and MRI
2015.12-2016.7
Study Arms (4)
CSD-TVU
Cesarean Section Scar Evaluation by TVU
CSD-MRI
Cesarean Section Scar Evaluation by MRI
CSD-MRI with saline
Cesarean Section Scar Evaluation by MRI with saline
CSD-Hysteroscopic
Cesarean Section Scar Evaluation by Saline Contrast Sonohysterography During Hysteroscopy
Interventions
Eligibility Criteria
cesarean section diverticula patients in our hospital from 2016 to Dec 2018.The diagnosis was confirmed on the basis of medical history (at least one C-section), clinical symptoms (post¬menstrual spotting, no significant change of cycle before and after C-section),transvaginal ultrasonography (TVU), and mag¬netic resonance imaging (MRI) findings
You may qualify if:
- cesarean section diverticula patients in our hospital from 2016 to Dec 2018.The diagnosis was confirmed on the basis of medical history (at least one C-section), clinical symptoms (post¬menstrual spotting, no significant change of cycle before and after C-section),transvaginal ultrasonography (TVU), and mag¬netic resonance imaging (MRI) findings
You may not qualify if:
- \) irregular menstrual cycle before cesar¬ean section; 2) previous placement of an intrauterine contracep¬tive device; and 3) presence of another organic uterine pathology responsible for abnormal uterine bleeding examined by hysteroscopy, such as endome-trial hyperplasia, endometrial polyps, malignancy, or submucosal myomas
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Gynecology, Shanghai First Maternity and Infant Hospital, affiliated to Tongji University
Shanghai, Shanghai Municipality, China
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Xipeng Wang
Department of Gynecology, Shanghai First Maternity and Infant Hospital, affiliated to Tongji University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 10, 2016
First Posted
August 12, 2016
Study Start
June 1, 2016
Primary Completion
June 1, 2018
Last Updated
August 12, 2016
Record last verified: 2016-08